A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
Clinical trial NCT07146126 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07146126
- Sponsor
- Prime Gene Therapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2026-06-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.